Frontline Management of Atopic Dermatitis in Adults - Episode 6

The Utility of Newer Topical Therapies for Atopic Dermatitis

Published on: March 3, 2025

Brad P. Glick, DO, MPH, Zed Zha, MD, FAAFP, Charles Vega, MD, FAAFP, Mona Shahriari, MD, FAAD, Michael R. Nazareth, MD, PhD, FAAD

Panelists discuss how upcoming topical therapeutics for atopic dermatitis include corticosteroid-sparing treatments like topical calcineurin inhibitors (eg, tacrolimus, pimecrolimus), Janus kinase (JAK) inhibitors (eg, ruxolitinib), and phosphodiesterase-4 inhibitors (eg, crisaborole) for effective symptom management.

EP. 1: Frontline Management of Atopic Dermatitis in Adults

EP. 2: Considerations for Diagnosis of Atopic Dermatitis in Adults

EP. 3: A Primary Care Perspective on Diagnosing Atopic Dermatitis

EP. 4: Strategies for Determining Severity of Atopic Dermatitis

EP. 5: Collaboration Between Primary Care and Dermatology in Atopic Dermatitis Care

Now Viewing

EP. 6: The Utility of Newer Topical Therapies for Atopic Dermatitis

EP. 7: The Impact of Biologics on a Changing Atopic Dermatitis Treatment Landscape

Video content above in prompted by the following:

Have the panelists had exposure to the newer therapeutics, such as topical JAK inhibitors?